Patents for A61K 49 - Preparations for testing in vivo (35,376)
08/2010
08/26/2010US20100215575 Systemic Administration of Chlorotoxin Agents for the Diagnosis and Treatment of Tumors
08/26/2010US20100215574 Process for producing an injectable medicament preparation
08/26/2010US20100215573 Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders
08/26/2010CA2752902A1 Synthetic diblock copolypeptide hydrogels for use in the central nervous system
08/26/2010CA2752373A1 Glutathione-based drug delivery system
08/25/2010EP2219736A2 Methods relating to breathing disorders
08/25/2010EP2219681A2 Imaging method
08/25/2010EP1435774B1 Enhanced resolution of tumor metastasis
08/25/2010EP0748228B8 powder FOR THE PROVOCATION OF AIR PASSAGE NARROWING AND/OR THE INDUCTION OF SPUTUM
08/25/2010CN101814352A Water-soluble rock salt type CoO nano flower-like magnetic particles and application thereof
08/25/2010CN101812528A Switch mode aptamer probe and application thereof in tumor living cell and vital detection
08/25/2010CN101812092A Manganese compound and preparation method and application thereof
08/25/2010CN101812027A Fluorescent pyrazine derivatives and methods of using the same in assessing renal function
08/25/2010CN101811192A Water-soluble monodisperse iron-nickel magnetic nanoparticles and application thereof
08/25/2010CN101810867A Medical disinfecting and sterilizing ultrasonic coupling agent and preparation method thereof
08/25/2010CN101810866A New method for screening anti-liver injury medicament by using model organism zebra fish
08/25/2010CN101810151A Method and dedicated inducer for building nudemice malignant ascites model associated with human ovarian cancer
08/24/2010US7781566 Peptides, mimetics and antibodies of erbB, TNF, and IgSF receptors; for preventing, treating, and diagnosing mammalian cancer tumors
08/24/2010US7781394 Methods for identifying anti-tumor and/or anti-angiogenesis drugs with deoxynucleoside 5′-monophosphate N-glycosidase as the target
08/24/2010US7780985 for assisting in the identification of a region on the tablet that is desired to be able to be broken; breaking allows production of smaller dosage forms
08/24/2010US7780953 Based on iron oxide, complexed by gem-bisphosphonate compounds, coupled to biovector (protein); colloids; peptization; for use as contrast agents for magnetic resonance imaging; labelling stem cells
08/24/2010US7780952 Distinguish between tumor cells and normal cells using novel contrast agents that contain a Magnetic Resonance Imaging (MRI) detectable moiety bound, optionally through a spacer, to a (pseudo)nutrient such as glucose, a natural or unnatural amino acid such as agmatine, or a polyamine such as spermidine
08/24/2010US7780951 Vaccines for immunization against Helicobacter
08/24/2010US7780949 reducing an accumulation of collagen associated with chronic kidney disease, renal fibrosis or renal sclerosis by administering to the human subject a full-length nephroblastoma overexpressed gene product or protein (CCN3)
08/24/2010US7780948 implanting post-procedure cavity implant into cavity through incision and through access path, and closing incision, wherein implanted post-procedure cavity implant swells within biological fluid environment of cavity to a post-implantation state and no longer fits through the access path
08/24/2010CA2329320C Chlorin and bacteriochlorin-based aminophenyl dtpa and n2s2 conjugates for mr contrast media and radiopharmaceuticals
08/19/2010WO2010094043A2 Gadolinium expressed lipid nanoparticles for magnetic resonance imaging
08/19/2010WO2010093635A2 Systems and methods for measuring and modeling in vivo manganese ion transport in a subject
08/19/2010WO2010093420A2 Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof
08/19/2010WO2010092917A1 Test reagent for fluorescent observation of intestinal mucosa
08/19/2010WO2010073126A3 Compounds useful in delivering anti-neoplastic therapy and diagnostic imaging to hypoxic cells and methods of use thereof
08/19/2010WO2010072752A3 Fluorescent probes having a polymeric backbone
08/19/2010WO2010062557A3 Multimodal imaging of atherosclerotic plaque targeted to lox-1
08/19/2010WO2010062536A3 Modified actinomycin-based nucleic acid stains and methods of their use
08/19/2010WO2010056590A3 Conjugates of 19f mr imaging tracers for use in multi-chromic mri imaging
08/19/2010WO2010048623A8 Medical and imaging nanoclusters
08/19/2010WO2010032248A3 Multifunctional albumin conjugates
08/19/2010US20100212029 Novel assays utilizing nicotinic acetylcholine receptor subunits
08/19/2010US20100209507 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
08/19/2010US20100209409 Method for suppressing immune system response to transplanted tissue or cells
08/19/2010US20100209356 Contrast agents
08/19/2010US20100209355 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; Using copper binding protein as a delivery vehicle; used to treat or prevent Cancer
08/19/2010US20100209354 Organic/inorganic hybrid nanoparticulates made from iron carboxylates
08/19/2010US20100209353 Tumor targeting protein conjugate and a method for preparing the same
08/19/2010US20100209352 Synthesis and conjugation of iron oxide nanoparticles to antibodies for targeting specific cells using fluorescence and mr imaging techniques
08/19/2010US20100209351 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
08/19/2010US20100209350 Biomarkers for Adipose Tissue Activity
08/19/2010US20100209349 Phage Therapy Against Pseudomonas Aeruginosa
08/19/2010US20100209348 Methods for determining liposome bioequivalence
08/19/2010US20100209347 Cyclodextrin compound modified with folic acid, process for production thereof, drug delivery agent for targeting drug delivery system, pharmaceutical composition, and imaging agent
08/19/2010US20100209346 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
08/19/2010US20100209344 Radio-methyl Vorozole and Methods for Making and Using the Same
08/19/2010US20100209343 Methods and kits for diagnosis of cancer and prediction of therapeutic value
08/19/2010US20100209342 Apcdd1 inhibitors for treating, diagnosing or detecting cancer
08/18/2010EP2217599A1 Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes
08/18/2010EP2217075A1 Uridine dietary supplementation compliance methods and use thereof
08/18/2010EP1631561B1 Compositions and methods for non-invasive imaging of soluble beta-amyloid
08/18/2010EP1443899B1 Bowel cleansing agent
08/18/2010EP0956865B2 MEDICINES COMPRISING Rho KINASE INHIBITOR
08/18/2010CN201551338U White mouse tester
08/18/2010CN1744906B Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method
08/18/2010CN101808684A Injection monitor
08/18/2010CN101808670A Golden mean harmonized water and aqueous solutions
08/18/2010CN101805751A Preparation for detecting male reproductive toxicity of environmental chemicals and modeling method
08/18/2010CN101805738A Peculiar p53 mutated protein-p53N236S of ALT tumor caused by progeria syndrome and application thereof
08/18/2010CN101805362A Porphyrin modified by diethylenetriamine pentaacetic acid gadolinium and preparation method and application thereof
08/18/2010CN101805328A epothilone derivatives
08/18/2010CN101804213A Methods and compositions for detection and diagnosis of infectious diseases
08/18/2010CN101804212A Technical method used for detecting degradation rule of dsRNA in animal body
08/18/2010CN101804211A Establishment of rhesus autoimmune 1 type diabetes model
08/18/2010CN101307018B Diethylene triaminepentaacetic acid carboxyl active ester or analogues, method for synthesizing same and use
08/18/2010CN101062422B The coupling matter between magnetic resonance imaging contrast agent based on metal fullerene and antibody and the detecting technology
08/17/2010US7778695 In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes
08/17/2010US7777024 Process for preparing a pentopyranosyl nucleic acid conjugate
08/17/2010US7776588 Identification of a truncation polymorphism of the mdr1 gene that is linked to ivermectin sensitivity in subjects such as collie dogs; use in bioassay testing to see which drugs certain canines will have adverse reactions to; pharmacogenetics
08/17/2010US7776340 has a low level of homology to the enteric canine coronavirus, but which has a high level of homology to all bovine coronavirus strains (eg Quebec and LY138) and human coronavirus strain OC43
08/17/2010US7776335 Microorganismal enzymatic polypeptide for use in developing vaccine for prevention and treatment of nesserial infection
08/17/2010US7776314 Abuse-proofed dosage system
08/17/2010US7776313 Methods of diagnosing and treating rheumatoid arthritis and osteoarthritis
08/17/2010US7776312 Method of treating Alzheimer's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity
08/17/2010US7776311 D-amino acid peptides
08/17/2010US7776310 non-polymeric biodegradable implantable seeds
08/17/2010CA2144527C Up-converting reporters for biological and other assays using laser excitation techniques
08/12/2010WO2010091142A1 Compositions and methods for labeling and imaging phospholipids
08/12/2010WO2010071293A3 Target indicator for radiological treatment
08/12/2010US20100202976 Substance-encapsulating carbon nanohorn aggregate and process for producing the same
08/12/2010US20100202975 Novel fluorescent derivatives of polyamines, method for preparing same and applications thereof as diagnosis tools in the treatment of cancerous tumors
08/12/2010US20100202974 Nano-scale contrast agents and methods of use
08/12/2010US20100202973 Microrna molecules associated with inflammatory skin disorders
08/12/2010US20100202972 Use of gene variants of the human meis1, btbd9, map2k5, lbxcor1, ptprd or a2bp1 gene for diagnostic and therapeutic approaches to restless legs syndrome (rls)
08/12/2010US20100202971 Compound having tumor-resident property
08/12/2010US20100202970 Intracellular reporters
08/12/2010US20100202969 Nanoparticles for imaging and treating chlamydial infection
08/12/2010US20100202968 Method of Providing Disease-Specific Binding Molecules and Targets
08/12/2010US20100202967 Fibrin binding pepetide conjugates for diagnostic and therapeutic applications
08/12/2010US20100202966 Implantable Sensor
08/12/2010US20100202964 Organ Homing Genes of Cancer Metastases
08/12/2010US20100202961 Immunological reagents for therapeutic use, in radioimmunotherapy (RAIT), and diagnostic use, in radioimmunodetection (RAID) and magnetic resonance imaging; conjugated drug as antiinflammatory, or anticarcinogenic agents; drug targets; tissue-targeted therapy
08/12/2010DE102005005704B4 Verwendung von Partikeln für die Ermittlung der lokalen Temperatur in organischen und nichtorganischen Körpern Use of particles for determining the local temperature in organic and inorganic bodies
08/11/2010EP2215107A1 Peptide ligand directed drug delivery
1 ... 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... 354